Research areas

  1. Published

    Oral methotrexate/6-mercaptopurine may be superior to a multidrug LSA2L2 Maintenance therapy for higher risk childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study

    Schmiegelow, K., Heyman, M., Kristinsson, J., Mogensen, U. B., Rosthøj, Susanne, Vettenranta, K., Wesenberg, F., Saarinen-Pihkala, U. & Nordic Society of Paediatric Haematology and Oncology (NOPHO), N. S. O. P. H. A. O. (., 2009, In: Journal of Pediatric Hematology/Oncology. 31, 6, p. 385-92 7 p.

    Research output: Contribution to journalJournal articlepeer-review

  2. Published

    Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy

    Schmiegelow, Kjeld, Muller, Klaus, Mogensen, S. S., Mogensen, P. R., Wolthers, B. O., Stoltze, U. K., Tuckuviene, R. & Frandsen, T., 2017, In: F1000Research. 6, 14 p., 444.

    Research output: Contribution to journalReviewpeer-review

  3. Published

    Yet another susceptibility variant for ALL: What’s next?

    Schmiegelow, Kjeld, Feb 2019, In: Blood. 133, 7, p. 628-629 2 p.

    Research output: Contribution to journalComment/debatepeer-review

  4. Published

    Maintenance therapy of childhood acute lymphoblastic leukemia revisited—Should drug doses be adjusted by white blood cell, neutrophil, or lymphocyte counts?

    Schmiegelow, Kjeld, Nersting, J., Nielsen, S. N., Heyman, M., Wesenberg, F., Kristinsson, J., Vettenranta, K., Schrøeder, H., Weinshilboum, R., Jensen, K. L., Grell, Kathrine & Rosthøj, Susanne, Dec 2016, In: Pediatric Blood & Cancer. 63, 12, p. 2104-2111 8 p.

    Research output: Contribution to journalJournal articlepeer-review

  5. Published

    SOHO State of the Art Updates and Next Questions: Management of Asparaginase Toxicity in Adolescents and Young Adults with Acute Lymphoblastic Leukemia

    Schmiegelow, Kjeld, Rank, C. U., Stock, W., Dworkin, E. & van der Sluis, I., 2021, In: Clinical Lymphoma, Myeloma and Leukemia. 21, 11, p. 725-733

    Research output: Contribution to journalReviewpeer-review

  6. Published

    EXABS-103-ALL Advances in ALL Diagnosis and Treatment -The NOPHO Experience

    Schmiegelow, Kjeld, 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, p. S6-S8

    Research output: Contribution to journalConference abstract in journalpeer-review

  7. Published

    Do cytogenetics of acute lymphoblastic leukaemia blasts affect required duration and intensity of maintenance therapy? Authors' reply

    Schmiegelow, Kjeld, Nielsen, S. N. & Grell, Kathrine, Jun 2017, In: The Lancet Oncology. 18, 6, p. e292 1 p.

    Research output: Contribution to journalComment/debate

  8. Published

    Have COVID-19 affected ALL epidemiology?

    Schmiegelow, Kjeld, 2021, In: Acta Paediatrica, International Journal of Paediatrics. 110, 2, p. 387-388 2 p.

    Research output: Contribution to journalEditorialpeer-review

  9. Published

    Management of Asparaginase Toxicity in AYAs with ALL

    Schmiegelow, Kjeld & Rank, C. U., Sep 2020, In: Clinical Lymphoma, Myeloma & Leukemia. 20, Suppl 1, p. S12-S13 2 p.

    Research output: Contribution to journalJournal articlepeer-review

  10. Published

    Maintenance therapy of childhood acute lymphoblastic leukemia: Do all roads lead to Rome?

    Schmiegelow, Kjeld, 2020, In: Pediatric Blood and Cancer. 67, 11, e28418.

    Research output: Contribution to journalComment/debatepeer-review